Generation Bio and Vir Biotechnology to Collaborate on Research to Leverage Scalable Non-Viral Gene Therapy Platform for Durable Production of Monoclonal Antibodies...
CAMBRIDGE, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Mar 30, 2020-- |!| Fort Madison
